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Abstract 
Background: Heart diseases are complex pathophysiologic conditions involving biomarkers. Understanding the 
mechanisms by which a gene selectively triggers intracellular molecular responses provide insight into the complex 
processes implicated in heart diseases. The aim of this study was to predict heart diseases associated genes. 
Materials and Methods: A number of computational methods have been developed for human gene 
prioritization. In this study, we used Beegle and KEGG pathway databases and two online services for gene 
prioritization and analysis of genes related to heart disease. 
Results: Over 200 genes and 5 key signaling pathways related to human heart diseases were found. The 
processes in which gene mutations trigger a response in cells leading to cardiac conditions involve multiple 
pathways. 
Conclusion: The genes related to heart diseases could be CRP, NPPB, IL-6, ACE2 and GATA4 with high scores 
and the researchers should find the diagnostic biomarker between them. 
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Heart disease accounts for a high percentage of 
morbidity and mortality worldwide. Several factors 
contribute to the progress of cardiac disorders 
including age, gender, low-density cholesterol, 
inflammation, hypertension, total cholesterol, 
hypercholesterolemia, alcohol consumption, diabetes, 
obesity, and smoking1. The risk of heart disease 
however cannot be explained only via these factors. 
Severity of these illnesses can be estimated more 
accurately via genetic factors2. So far, a number of 
computational methods have been developed for 
prioritization of human genes. In this investigation, 
online databases and literature review were used to 
identify and prioritize genes involved in heart disease. 
Beegle and KEGG pathway databases were used to 
facilitate this. Beegle is an online service that 
automatically analyzes literature to find the genes most 
related to a particular query and prioritize a set of 
candidate genes. Beegle was given the query heart 
disease. As per literature review, Beegle was first used 
to rank the genes related to heart disease. Pathways 
involving these genes were then further investigated. 
KEGG (Kyoto Encyclopedia of Genes and Genomes) 
pathway database provided a systematic analysis of 
gene functions and the graphical plot of molecular 
interactions, reactions and relation networks. 
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Methods 
In addition to ranking, the genes related to the query, 
Beegle provided further information including 
supporting publications15. This service was available 
at http://beegle.esat.kuleuven.be/. For this purpose, 
KEGG pathway database was used. KEGG was 
publicly available at 
https://www.genome.jp/kegg/pathway.html. 
According to data extracted from this server, five 
pathways for heart diseases were found. 
Results 
Gene analysis: According to Beegle webserver, over 
200 genes related to heart disease were found. The 
most important genes with the highest ranks were 
listed in table-1. C-reactive protein had the highest 
rank. 
Pathway analysis: The cellular elements of 
cardiovascular system are composed of several 
specific receptors and complex intracellular pathways. 
They provide appropriate responses to extracellular 
stimuli. In this part of the study, using KEGG pathway 
database, five major signaling pathways in cardiac and 
vascular cells was identified. These pathways provide a 
general overview of major genes associated with 
cardiovascular disease. 
Fluid shear stress and atherosclerosis: Shear stress 
described as the frictional force of blood on the 
endothelial layer of a vessel. This force contributes to 
morphological changes of blood vessel walls as well as 
complex biological responses3. Shear stress can also 
up-regulate the expression of genes implicated in the 
anti-atherosclerotic function of endothelial cells4. 
Hypertrophic cardiomyopathy (HCM): HCM is one of 
the most common inherited heart disorders. It 
characterized by left ventricular hypertrophy with 
histological features such as myocyte hypertrophy, 
interstitial fibrosis and myofibrillar disarray. Over 400 
different mutations have been identified to cause 
myofilament sensitivity to Ca2+ in HCM5.  
Arrhythmogenic right ventricular cardiomyopathy  
Table 1: Genes related to heart disease with higher ranks according to Beegle. 
Gene symbol Gene name 
CRP C-reactive protein, pentraxin-related 
NPPB natriuretic peptide B 
IL-6 interleukin 6 
ACE2 angiotensin I converting enzyme 2 
GATA4 GATA binding protein 4 
AGER advanced glycosylation end product-specific receptor 
AGTR1 angiotensin II receptor, type 1 
SIRT1 sirtuin 1 
HMOX1 heme oxygenase (decycling) 1 
NKX2-5 1482 
LGALS3 lectin, galactoside-binding, soluble, 3 
NOS3 nitric oxide synthase 3 (endothelial cell) 
TNNT2 troponin T type 2 (cardiac) 
ADM Adrenomedullin 
GHRL ghrelin/obestatin prepropeptide 
RYR2 ryanodine receptor 2 (cardiac) 
TTR Transthyretin 
SCN5A sodium channel, voltage gated, type V alpha subunit 
TNN13 troponin I type 3 (cardiac) 
NPPC natriuretic peptide C 
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(ARVC): ARVC is an inherited cardiomyopathy with 
autosomal dominant inheritance pattern6. So far, 
several genetic mutations have been identified that 
play a critical role in ARVC.  
Dilated cardiomyopathy (DCM): DCM is a 
myocardial disease characterized by the enlargement 
of the right or left ventricle, or both. The prevalence is 
estimated to be 1 in 2500-3000 and increases with 
age7. Familial DCM is the inherited form of DCM 
caused by several mutations, which mostly occur in 
genes encoding mitochondrial, cytoskeletal, 
nucleoskeletal, and calcium-handling proteins.  
Myocarditis: Myocarditis is defined as an 
inflammatory heart disease that results from both viral 
and non-viral etiologies. Viral myocarditis is more 
prevalent8. Many virus types can produce myocarditis. 
Among them are: coxsackie virus B3 (CVB3), 
parvoviruses, echoviruses, adenovirus, influenza 
H1N1, Epstein–Barr, mumps, rubella, varicella, 
measles , yellow fever, Zika , polio, hepatitis A and C, 
rabies, and human immunodeficiency viruses. 
Discussion 
Heart disease is a complex condition in which several 
factors and biomarkers are involved. Understanding the 
mechanisms by which a gene selectively induces 
intracellular molecular responses, provides insight into 
complex processes causing heart conditions. Heart 
 
 




Figure 2. Hypertrophic cardiomyopathy and related genes in confirmed pathway. 
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disease associated genes lead to one of two different 
pathologies: hypertrophy (HCM) and dilation (DCM). 
In hypertrophy, wall thickness is increased without 
chamber expansion; however, in dilation, walls are 
 
 




Figure 4. Dilated cardiomyopathy (DCM) and related genes in recorded pathway. 
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normal or thin but chamber volume is increased. 
Furthermore a number of serum markers such as C-
reactive protein (CRP), phospholipase A2 (PLA2), 
Nitric oxide synthase3 (NOS3), apolipoprotein C3 
(APOC3), proprotein convertase subtilisin/kexin 
type9 (PCSK9), fibroblast growth factor23 (FGF23), 
interleukin-10 (IL-10), endotelin1 (EDN1), low 
density lipoprotein receptor (LDLR), CD39, 
interleukin-6 (IL-6), GATA4, and CD44 have been 
identified to be involved in the initiation and 
progression of heart disease. According to our 
findings, Heart disease genes that cause either HCM 
or DCM, include: β-cardiac myosin heavy chain 
(MYH7), TTN, cardiac actin (ACTC), TNNT2, α-
tropomyosin (TPM1), TNNI3, and myosin light chain 
(MYL3 and MYL2)9. Mutations in sarcomere protein 
genes leading to DCM are different from those in 
HCM. Different amino acids affecting in each 
category-giving rise to diverse types of cellular 
malfunction. As mentioned earlier the development of 
DCM or HCM depends on the type of mutation. Some 
mutations result exclusively in mild left ventricular 
hypertrophy (HCM), while TNNT2 mutations often 
result in heart failure (DCM) and sudden death. 
Sarcomere homozygous mutations in either TNNT2 or 
MYH7 lead to severe hypertrophies. According to 
clinical genetic experiments, MYH7, TNNT2 and 
TPM1 mutations are involved in nearly 2 to 4% of 
DCM cases10. It is also notable that, there are a number 
of mutations occurring in the giant protein titin. 
Mutations in TTN account for about 25% of DCM 
cases11. Defects in nuclear genes such as Lamin A/C are 
also linked to DCM32. Mutations in desmosomal genes 
can result in myocyte hypersensitivity in response to 
right ventricular cardiomyopathy and mechanical 
stress. Also mutations in plakoglobin, desmoplakin, 
plakophilin-2, and RyR2 (a calcium channel in 
sarcoplasmic reticulum membrane of myocytes) have 
been found in ARVD12. Cell surface mechanic-sensors 
are sensitive to shear stress. Shear stress can induce 
various intracellular pathways. Many of these pathways 
are linked to common signaling pathways, such as the 
Ras/MAPK and the PI3K/Akt pathway13. In laminar 
shear stress, athero-protective proteins, such as NOS-3 
become phosphorylated and up-regulated by Akt in a 
PI3K-dependent pathway. EDN1, a strong 
vasoconstrictor, is a functional partner of NOS-3 in the 
regulative process of laminar shear and cardiovascular 
 
 
Figure 5. Viral myocarditis and related genes in recorded pathway. 
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development. Thus, EDN-1 and NOS-3 are essential 
for maintaining vascular homeostasis35. EDN-1 has a 
critical role in both fluid shear stress and HCM 
pathways14. In addition, EDN1 promotes expression, 
phosphorylation, and activation of GATA4 gene in 
myocytes. This leads to heightened iNOS activity and 
therefore increased nitric oxide production. Zinc 
finger transcription factor GATA4 also seems to play 
an important role in the pathology of HCM response15. 
It has been reported that CRP, an acute phase-reactant 
protein, is strongly implicated in cardiac disease. This 
protein is often made in the liver in response to IL-6 
and plays several pathophysiological roles in the 
inflammatory process. Elevated CRP levels in heart 
disease suggest this inflammatory biomarker may be 
directly involved in the pathogenesis of these 
disorders. CRP can induce apoptosis in myocardial 
cells, and produce ventricular injury or dysfunction 
resulting in HCM or DCM38. Studies also revealed 
that serum levels of IL-6 are elevated in both DCM 
and HCM16. More than 50 genes are associated with 
DCM including: TTN (Titin), BAG3 (BCL2-
associated athanogene 3), ABCC9 (ATP-binding 
cassette, sub-family C, member 9), TTR 
(Transthyretin), TNNI3 (Troponin I type 3), TMPO 
(Thymopoietin), TNNC1 (Troponin C type 1), CTF1 
(Cardiotrophin 1), DES (Desmin), DMD 
(Dystrophin), LMNA (Lamin A/C), TNNT2 
(Troponin T type 2), PLN (Phospholamban)10. These 
genes often encode desmosomal proteins such as 
plakophilin-2 (PKP2), desmoglein-2 (DSG2), 
desmoplakin (DSP) and desmocollin-2 (DSC2). 
Mutations in components of the cardiac desmosome 
result in disruption of desmosomal function, as well as 
heart failure17. Several mutations in genes encoding 
for non-desmosomal proteins have also been reported. 
These include Transforming growth factor-β3 
(TGFB3), ryanodine receptor 2 (RYR2), trans 
membrane protein 43 (TMEM43) and sodium 
voltage-gated channel alpha subunit, 5 (SCN5A). In 
summary, myocardial failure followed by genetic 
disorders may lead to inflammation and cell 
apoptosis18. It has been found that inflammatory 
biomarkers including IL-1, IL-6 and CRP are involved 
in HCM. Under various forms of stress, IL-6 is 
expressed in myocardium. It can modulate the 
function of myocardium through a variety of 
mechanisms, including the induction of left ventricular 
hypertrophy, cardiomyopathy, and apoptosis in cardiac 
myocytes. IL-6 level elevates in response to muscle 
contraction and can be found in both skeletal and 
smooth muscle as a pro-inflammatory cytokine19. 
Endothelin-1 (EDN-1) is also increased as a potent 
vasoconstrictor and contributes to hypertrophy in 
HCM. Researchers showed that increased pressure in 
hypertrophied heart resulted in over-expression of 
EDN-120. 
Conclusion 
Single-gene abnormalities contribute to a tiny fraction 
of heart disease in humans. The process in which a gene 
mutation induces a response in cells depends on several 
factors including other genes. Bioinformatics analysis 
can be helpful in categorizing and remodeling the 
complex process of responses leading to heart disease. 
The genes related to heart diseases can be CRP, NPPB, 
IL-6, ACE2 and GATA4 with high scores and the 
researchers should find the diagnostic biomarker 
between them. In continue for a special heart disorder 
the others like eNOS3, HCM, PKP2, DSG2, TTN, 
BAG3, ABCC9 and CVB3 have the critical roles. 
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